drugset / Trial / NCT00235898

Clinical Trial in Patients With Metastatic Colorectal Cancer

NCT00235898 ↗

Phase 2 Completed 300 enrolled Mast Therapeutics, Inc.
RandomizedParallel-groupOpen-labelTreatment

Summary

The objective of this trial is to compare efficacy and safety of CoFactor and 5-fluorouracil (5-FU) versus leucovorin and 5-FU in treatment of metastatic colorectal cancer.

Timeline

Start
2005-05
Primary completion
2008-03
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject FOLITIXORIN Small molecule — —
Comparator Leucovorin Small molecule — —
Background fluorouracil Small molecule — —